# Platelet-Directed Whole Blood Transfusion Strategy for Malaria

> **NCT05711485** · NA · RECRUITING · sponsor: **Johns Hopkins Bloomberg School of Public Health** · enrollment: 132 (estimated)

## Conditions studied

- Severe Malaria
- Thrombocytopenia

## Interventions

- **OTHER:** Whole blood transfusion

## Key facts

- **NCT ID:** NCT05711485
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-24
- **Primary completion:** 2027-04-30
- **Final completion:** 2028-05-31
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2025-10-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05711485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05711485, "Platelet-Directed Whole Blood Transfusion Strategy for Malaria". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05711485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*